Patents by Inventor Chris Lloyd

Chris Lloyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOY
    Publication number: 20250114718
    Abstract: There is provided a toy, including a ball chasing robot including: a controller configured to receive power from a battery a plurality of infrared sensors configured to detect infrared radiation emitted by a satellite object, the plurality of infrared sensors connected to the controller; a motor configured to drive a wheel arrangement, the wheel arrangement including at least two drive wheels, wherein: the controller is configured to control the motor and wheel arrangement to drive the ball chasing robot towards the infrared radiation emitted by the satellite object detected by the plurality of infrared sensors; wherein the ball chasing robot includes a plurality of settings, including: a play setting, wherein the controller is configured to control the motor, such that the ball chasing robot is driven towards the source of the infrared radiation emitted by the satellite object, and a sleep setting wherein the controller is configured to turn off the plurality of sensors, wherein the sleep setting is entered
    Type: Application
    Filed: October 10, 2023
    Publication date: April 10, 2025
    Inventors: Barry HUGHES, Gareth LLOYD, Chris MARSDEN, Oliver HALES
  • Patent number: 12098191
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: September 24, 2024
    Assignee: MEDIMMUNE LIMITED
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgard
  • Publication number: 20240294619
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: March 14, 2024
    Publication date: September 5, 2024
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Publication number: 20220251181
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: February 16, 2022
    Publication date: August 11, 2022
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgard
  • Patent number: 11286297
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: March 29, 2022
    Assignee: MEDIMMUNE LIMITED
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Publication number: 20210009665
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: May 1, 2020
    Publication date: January 14, 2021
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Patent number: 10662239
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: May 26, 2020
    Assignee: MedImmune Limited
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Publication number: 20180105585
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: October 25, 2017
    Publication date: April 19, 2018
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Patent number: 9834598
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: December 5, 2017
    Assignee: MedImmune Limited
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Publication number: 20150299299
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: October 15, 2013
    Publication date: October 22, 2015
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne
  • Patent number: 8333255
    Abstract: High productivity core drilling systems include a drill string, an inner core barrel assembly, an outer core barrel assembly, and a retrieval tool that connects the inner core barrel assembly to a wireline cable and hoist. The drill string comprises multiple variable geometry drill rods. The inner core barrel assembly comprises a non-dragging latching mechanism, such as a fluid-driven latching mechanism that contains a detent mechanism that retains the latches in either an engaged or a retracted position. The inner core barrel assembly also comprised high efficiency fluid porting.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: December 18, 2012
    Assignee: Longyear TM, Inc.
    Inventor: Chris Lloyd Drenth
  • Publication number: 20100012383
    Abstract: High productivity core drilling systems are described. The system includes a drill string, an inner core barrel assembly, an outer core barrel assembly, and a retrieval tool that connects the inner core barrel assembly to a wireline cable and hoist. The drill string comprises multiple variable geometry drill rods. The inner core barrel assembly comprises a non-dragging latching mechanism, such as a fluid-driven latching mechanism that contains a detent mechanism that retains the latches in either an engaged or a retracted position. The inner core barrel assembly also comprised high efficiency fluid porting. Accordingly, the drilling system significantly increases productivity and efficiency in core drilling operations by reducing the time required for the inner core barrel assembly to travel through the drill string. Other embodiments are also described.
    Type: Application
    Filed: March 3, 2008
    Publication date: January 21, 2010
    Applicant: LONGYEAR TM, INC.
    Inventor: Chris Lloyd Drenth
  • Patent number: D767508
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: September 27, 2016
    Assignee: Lutron Electronics Co., Inc
    Inventors: Chris Lloyd Dimberg, Elliot G. Jacoby, Jason C. Killo, Brad Michael Kreschollek, Matthew Philip McDonald
  • Patent number: D899383
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: October 20, 2020
    Assignee: Lutron Technology Company LLC
    Inventors: Chris Lloyd Dimberg, Elliot G. Jacoby, Jason C. Killo, Brad Michael Kreschollek, Matthew Philip McDonald
  • Patent number: D929350
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: August 31, 2021
    Assignee: Lutron Technology Company LLC
    Inventors: Chris Lloyd Dimberg, Elliot G. Jacoby, Jason C. Killo, Brad Michael Kreschollek, Matthew Philip McDonald
  • Patent number: D975662
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: January 17, 2023
    Assignee: Lutron Technology Company LLC
    Inventors: Chris Lloyd Dimberg, Elliot G. Jacoby, Jason C. Killo, Brad Michael Kreschollek, Matthew Philip McDonald